The multicenter clinical study of the relation between a SGLT2 inhibitor and the hormones regulating appetite in the patients with type 2 diabetes
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000020086
- Lead Sponsor
- Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with an allergy to Canagliflozin 2. Patients with diabetic ketoacidosis, diabetic coma and type 1 diabetes 3. Patients with over 2 times from upper limit of normal ranges of AST, ALT, or gamma-GTP 4. Patients with under 45 ml/min/1.73m2 of eGFR 5. Patients with severe inflammation or injury, or before or after operation 6. Patients with cancer or inflammatory bowel disease, or after operation of GI tracts 7. Patients with pregnancy or during lactation 8. Patients who are thought to be unsuitable for the study by the attending doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method